A Delaware court has ruled in favor of a biotech startup in a high-stakes lawsuit involving allegations of misappropriated trade secrets related to cancer treatment.
Investors of Talis Biomedical Corp. have reached a $32.5 million settlement in a case accusing the company of inflating its stock price before a failed COVID-19 diagnostic test launch. The settlement
The Second Circuit upheld $33.5M in damages and sanctions against H&H Wholesale in a nearly decade-long trademark case involving the diversion of Abbott’s diabetes test strips.
A Washington federal judge dismissed part of the FTC’s monopolization case against Amazon. The trial will be split into two phases, but the order remains sealed.
